Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renata Staniszewska

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Medicinal Chemistry|January 29, 2008
Endomorphin analogsAnna Janecka, Renata Staniszewska, Jakub Fichna
Peptides|August 23, 2008
Enzymatic degradation of endomorphinsAnna Janecka, Renata Staniszewska, Katarzyna Gach, et al.
Chemical Biology & Drug Design|August 28, 2007
Mu-opioid receptor ligands lack receptor subtype selectivity in the aequorin luminescence-based calcium assayJakub Fichna, Renata Staniszewska, Jeroen Poels, et al.
Chemical Biology & Drug Design|June 20, 2008
Synthesis and biological activity of endomorphin-2 analogs incorporating piperidine-2-, 3- or 4-carboxylic acids instead of proline in position 2Renata Staniszewska, Jakub Fichna, Katarzyna Gach, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structureJakub Fichna, Jean-Claude do-Rego, Tomasz Janecki, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry|January 29, 2008
Endomorphin analogsAnna Janecka, Renata Staniszewska, Jakub Fichna
Peptides|August 23, 2008
Enzymatic degradation of endomorphinsAnna Janecka, Renata Staniszewska, Katarzyna Gach, et al.
Chemical Biology & Drug Design|August 28, 2007
Mu-opioid receptor ligands lack receptor subtype selectivity in the aequorin luminescence-based calcium assayJakub Fichna, Renata Staniszewska, Jeroen Poels, et al.
Chemical Biology & Drug Design|June 20, 2008
Synthesis and biological activity of endomorphin-2 analogs incorporating piperidine-2-, 3- or 4-carboxylic acids instead of proline in position 2Renata Staniszewska, Jakub Fichna, Katarzyna Gach, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structureJakub Fichna, Jean-Claude do-Rego, Tomasz Janecki, et al.
Pageof 1